Literature DB >> 11819388

Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles.

Yi-Mu Yi, Tang-Yu Yang, Wei-Min Pan.   

Abstract

AIM:To prepare 5-FU sodium alginate(125)I bovine serum albumin nanoparticles (BSA NP), to determine the radioactive count in different organs of rats at different time points after oral administration of 5-FU (125)I sodium alginate-BSA NP and to calculate the kinetic parameters of its metabolism.
METHODS: Emulsion solidification method was used to prepare 5-FU (125)I sodium alginate-BSA NP, and to determine its diameter under transmission electronic microscope (TEM). Then the rate of NP and external drug releasing velocity were measured. Radioactive counting in different organs of rats was made after oral administration of the NP by GAMA Counter, and the kinetic parameters of drug metabolism were calculated by handling the data with the two-department model.
RESULTS: The average arithmatic diameter of the NP was 166nm ± 34nm, the rate of 5-FU was 32.8% and the cumulative external releasing ratio amounted to 84.0% within 72 hours. The NP was mainly distributed in the liver, spleen, lungs and kidneys after NP oral administration to rats. The micro-radioautographic experiment showed that NP was distributed in the Kupffers cells of liver, liver parenchymal cells and the phagocytes of spleen and lungs. The kinetic parameters of matabolism were: T(1/2) = 9.42h, C(max) = 2.45X10(7)Bq,T(max) = 2.18h, AUC = 148X10(9)Bq.
CONCLUSION: NP is difficult to pass through the blood-cerebral barrier,and (125)I sodium alginate-BSA NP enters the body-circulation by gastroin testinal passage.

Entities:  

Year:  1999        PMID: 11819388      PMCID: PMC4688503          DOI: 10.3748/wjg.v5.i1.57

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  3 in total

1.  Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice.

Authors:  J L De Keyser; J H Poupaert; P Dumont
Journal:  J Pharm Sci       Date:  1991-01       Impact factor: 3.534

2.  In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules.

Authors:  N Ammoury; H Fessi; J P Devissaguet; F Puisieux; S Benita
Journal:  J Pharm Sci       Date:  1990-09       Impact factor: 3.534

3.  Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice.

Authors:  A Rolland; B Collet; R Le Verge; L Toujas
Journal:  J Pharm Sci       Date:  1989-06       Impact factor: 3.534

  3 in total
  7 in total

1.  Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles.

Authors:  P Vijayaraj Kumar; Narendr K Jain
Journal:  AAPS PharmSciTech       Date:  2007-03-02       Impact factor: 3.246

Review 2.  Biopolymeric nanoparticles.

Authors:  Sushmitha Sundar; Joydip Kundu; Subhas C Kundu
Journal:  Sci Technol Adv Mater       Date:  2010-02-26       Impact factor: 8.090

3.  Influence of formulation factors on the preparation of zein nanoparticles.

Authors:  Satheesh Podaralla; Omathanu Perumal
Journal:  AAPS PharmSciTech       Date:  2012-06-26       Impact factor: 3.246

4.  Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.

Authors:  Mahesh D Chavanpatil; Ayman Khdair; Jayanth Panyam
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

5.  Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats.

Authors:  Yin-Cheng He; Ji-Wei Chen; Jun Cao; Ding-Yu Pan; Jian-Guo Qiao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

6.  Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization.

Authors:  A Martínez; R Olmo; I Iglesias; J M Teijón; M D Blanco
Journal:  Pharm Res       Date:  2013-08-07       Impact factor: 4.200

Review 7.  Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.

Authors:  Alejandro Sosnik
Journal:  ISRN Pharm       Date:  2014-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.